NeuroPace announced preliminary one-year results from its clinical study evaluating neuromodulation therapy for generalized ...

NeuroPace's RNS System trial showed a strong safety profile and subgroup efficacy in drug-resistant epilepsy, prompting FDA ...

"We view the totality of the data in the NAUTILUS study as a meaningful catalyst that adds to the growing body of evidence and momentum in our business,” said Joel Becker, Chief Executive Officer.

Design: Retrospective study of children born to mothers with epilepsy. Setting: Regional epilepsy clinics in Liverpool and Manchester, UK. Participants: Children aged between 6 months and 16 years ...

Absence seizures are a type of epilepsy. This is a condition that causes seizures. Seizures are caused by abnormal brain activity. These mixed messages confuse your brain and cause a seizure. An ...

Scientists say they've put together a molecular toolkit that could be used to treat a variety of brain diseases, possibly including epilepsy, ...

In a scientific first, researchers from around 29 universities and institutions across North America have teamed up to create ...